scispace - formally typeset
K

Kaixian Chen

Researcher at Chinese Academy of Sciences

Publications -  403
Citations -  11476

Kaixian Chen is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Virtual screening & Chemistry. The author has an hindex of 47, co-authored 380 publications receiving 9209 citations. Previous affiliations of Kaixian Chen include Shanghai University & East China University of Science and Technology.

Papers
More filters
Journal ArticleDOI

Mutagenic probability estimation of chemical compounds by a novel molecular electrophilicity vector and support vector machine

TL;DR: A novel molecular electrophilicity vector is first devised to represent the structure profile of chemical compounds and an extended support vector machine (SVM) method is used to derive the posterior probabilistic estimation of mutagenicity from the MEVs of the training set.
Journal ArticleDOI

Smart Tumor Microenvironment-Responsive Nanotheranostic Agent for Effective Cancer Therapy

TL;DR: In vivo pharmacodynamics results demonstrate that these synergetic effects caused by CaM‐PB NPs significantly contribute to the inhibition of tumor progression, demonstrating that theCaM‐ PB NPs with sequential theranostic functions are a promising system for effective cancer therapy.
Journal ArticleDOI

Pyrazolidine-3,5-dione derivatives as potent non-steroidal agonists of farnesoid X receptor: virtual screening, synthesis, and biological evaluation.

TL;DR: The novel structural scaffold has provided a new direction for finding potent and selective FXR partial and full agonists (referred to as 'selective bile acid receptor modulators', SBARMs).
Journal ArticleDOI

Dual role of Zn2+ in maintaining structural integrity and suppressing deacetylase activity of SIRT1.

TL;DR: The results indicate that Zn(2+) plays a dual role in SIRT1 activity and may also bind to another site different from the zinc-finger motif or the binding sites for the substrates or resveratrol and act as a potent inhibitor of SIRT2.
Journal ArticleDOI

Benzbromarone, an old uricosuric drug, inhibits human fatty acid binding protein 4 in vitro and lowers the blood glucose level in db/db mice

TL;DR: Oral administration of BBR dose-dependently reduced the blood glucose level and improved glucose tolerance and insulin resistance in db/db mice and revealed that the residues Ser55, Asp76, and Arg126 of FABP4 formed important interactions with BBR, which was confirmed by site-directed mutagenesis studies.